bromocriptine has been researched along with Hyperglycemia, Postprandial in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Baumgartner, AD; Gross, S; Lyon, E; Nadeau, KJ; Polsky, S; Schafer, M; Schauer, IE; Snell-Bergeon, JK; Tell, SS; Vigers, T | 1 |
Blonde, L; Chamarthi, B; Cincotta, AH; Ezrokhi, M; Gaziano, JM; Rutty, D; Scranton, RE; Vinik, A | 1 |
Belavic, JM | 1 |
Bell, DS | 1 |
Cincotta, AH; Liang, Y; Lubkin, M; Scislowski, PW; Sheng, H | 1 |
Cincotta, AH; Kraszewski, KZ | 1 |
Coimbra, CC; Fóscolo, RB; Guerra, RM; Marubayashi, U; Reis, AM; Ribeiro-de-Oliveira, A | 1 |
Cincotta, AH; Liang, Y | 1 |
Cai, P; Dai, J; Pan, L; Wang, B; Wang, E; Zhang, N; Zhang, W | 1 |
Cincotta, AH; Lovell, WC; Meier, AH | 1 |
Cincotta, AH; Meier, AH; Schiller, BC | 1 |
Abu-Jayyab, AR; Ageel, AM; el-Denshary, ES; el-Wakkad, I; Mohamed, HF | 1 |
1 review(s) available for bromocriptine and Hyperglycemia, Postprandial
Article | Year |
---|---|
Focusing on cardiovascular disease in type 2 diabetes mellitus: an introduction to bromocriptine QR.
Topics: Blood Glucose; Bromocriptine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dopamine Agonists; Humans; Hyperglycemia; Risk Assessment | 2012 |
3 trial(s) available for bromocriptine and Hyperglycemia, Postprandial
Article | Year |
---|---|
Bromocriptine quick-release as adjunct therapy in youth and adults with type 1 diabetes: A randomized, placebo-controlled crossover study.
Topics: Adolescent; Adult; Blood Glucose; Blood Glucose Self-Monitoring; Bromocriptine; Child; Creatinine; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Insulin; Insulin Resistance; Lipids; Middle Aged; Young Adult | 2022 |
Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus.
Topics: Aged; Blood Glucose; Bromocriptine; Cardiovascular Diseases; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Disease Progression; Dopamine Agonists; Double-Blind Method; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Treatment Outcome | 2015 |
Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics.
Topics: Body Composition; Bromocriptine; Diabetes Mellitus, Type 2; Fats; Female; Humans; Hyperglycemia; Male; Menopause; Obesity; Skinfold Thickness | 1992 |
8 other study(ies) available for bromocriptine and Hyperglycemia, Postprandial
Article | Year |
---|---|
A new treatment option for type 2 diabetes.
Topics: Bromocriptine; Diabetes Mellitus, Type 2; Hormone Antagonists; Humans; Hyperglycemia; Nurse Practitioners | 2010 |
Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Blood Glucose; Bromocriptine; Colforsin; Cyclic AMP; Dopamine Agonists; Glucokinase; Glucose; Hexokinase; Hyperglycemia; Hyperlipidemias; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Lipids; Mice; Mice, Inbred C57BL; Mice, Obese; Protein Kinase C; Tetradecanoylphorbol Acetate | 1998 |
Increased responsiveness of ventromedial hypothalamic neurons to norepinephrine in obese versus lean mice: relation to the metabolic syndrome.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Dopamine Agonists; Electrophysiology; Female; Glutamic Acid; Hyperglycemia; Iontophoresis; Mice; Mice, Inbred C57BL; Mice, Obese; Neurons; Norepinephrine; Obesity; Receptors, Dopamine D1; Receptors, Dopamine D2; Syndrome; Ventromedial Hypothalamic Nucleus | 2000 |
Bromocriptine-induced dissociation of hyperglycemia and prolactin response to restraint.
Topics: Animals; Blood Glucose; Bromocriptine; Dopamine Agonists; Hyperglycemia; Insulin; Male; Prolactin; Rats; Rats, Wistar; Restraint, Physical; Stress, Physiological | 2001 |
Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Agonists; Animals; Blood Glucose; Bromocriptine; Dopamine Agonists; Female; Glucagon; Glucose Clamp Technique; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Secretion; Mice; Mice, Inbred C57BL; Mice, Obese; Norepinephrine; Random Allocation | 2001 |
Gamma Knife radiosurgery as a primary surgical treatment for hypersecreting pituitary adenomas.
Topics: Adenoma; Adenoma, Acidophil; Adenoma, Basophil; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Human Growth Hormone; Humans; Hyperglycemia; Hyperprolactinemia; Hypertension; Infertility, Female; Male; Middle Aged; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Outcome; Prolactin; Prolactinoma; Radiosurgery; Safety; Treatment Outcome | 2000 |
Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Bromocriptine; Cricetinae; Female; Glucose Tolerance Test; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Mesocricetus; Obesity; Seasons | 1991 |
Mechanism of bromocriptine-induced hyperglycaemia.
Topics: Adrenalectomy; Animals; Bromocriptine; Corticosterone; Hyperglycemia; Insulin; Liver Glycogen; Male; Mice; Rats; Thyroxine; Triiodothyronine | 1985 |